Pharmaceuticals

Legacy Pharmaceutical Reduces Distribution Costs

Dave-Spence-thumb3

Legacy Pharmaceutical Packaging, which is headquartered in St. Louis, Miss., is not your typical contract packager, Dave Spence, chief executive officer, will tell you. The company has figured out a way to eliminate several steps from the pharmaceutical distribution model. Here’s how it works: The pharmaceutical manufacturer sends its products to Legacy in bulk, and […]

VN:F [1.9.7_1111]
Rating: +9 (from 9 votes)
0 comments Read the full article →

Larksfield Place Transitions to Automated Medication Dispensing

Reg-Hislop-thumb

As hospitals and other healthcare facilities rapidly change to meet new demands and implement technology, post-acute care and skilled nursing facilities have lagged, often because of legal and policy issues. Larksfield Place, a not-for-profit Continuing Care Retirement Community, has implemented a major initiative to transform medication delivery. President and Chief Executive Officer Reg Hislop came […]

VN:F [1.9.7_1111]
Rating: +11 (from 11 votes)
0 comments Read the full article →

PBOI Pioneers Two Groundbreaking Initiatives

Brian-Bizub-thumb2

Brian Bizub, Chief Executive Officer, Palm Beach Orthopaedic Institute by Pete Fernbaugh Brian Bizub has been chief executive officer of Palm Beach Orthopaedic Institute (PBOI) in Palm Beach Garden, Fla., for the past six years after working for Tenet Healthcare in various hospital administrative roles for 12 years. When he joined PBOI, he brought a […]

VN:F [1.9.7_1111]
Rating: +2 (from 2 votes)
0 comments Read the full article →

Palm Beach Orthopaedic Spearheads Post-Surgical DME Program

Brian-Bizub-thumb

Brian Bizub, chief executive officer of Palm Beach Orthopaedic Institute in West Palm Beach, Fla., discusses two initiatives: implementing a post-surgical DME program and opening commercial pharmacies in physician group practice offices.  

VN:F [1.9.7_1111]
Rating: +3 (from 3 votes)
0 comments Read the full article →

Wholesaler Provides Support that Saves Hospitals Money on Pharmaceuticals

Scott-Wilson-thumb

Within the field of drug distribution, an avalanche of branded drugs going off patent and the influx of multiple generic alternatives has materially changed market dynamics. National healthcare wholesaler and solutions provider H. D. Smith is taking advantage of the numerous savings that can be found within the drug market today by providing support to […]

VN:F [1.9.7_1111]
Rating: +4 (from 4 votes)
0 comments Read the full article →

Shionogi, Inc.: Deanne Melloy, Executive Vice President and Chief Operating Officer

When Shionogi Inc., was first established in the United States a little over a year ago by its Japanese parent company, Shionogi & Co. Ltd., it had the benefit of an 11-year presence in the U.S. marketplace. However, that presence didn’t actually become commercial until a recent acquisition. As Deanne Melloy, executive vice president and […]

VN:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

PRA: Kent Thoelke, Executive Vice President of Scientific and Medical Affairs

Clinical trial accrual in the United States runs around 3 percent and often takes a “keep your fingers crossed” approach. Up to the point of beginning clinical trials, drug development follows detailed research and design processes steeped in scientific methodology. One contract research organization (CRO) is working to change the landscape of clinical-trial design and […]

VN:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Hospitals and Pharmacies Partner to Lower Patient Readmissions

Reducing patient readmissions, especially among Medicare patients, is one of the greatest challenges facing the healthcare executives that HCE has had the privilege of interviewing and profiling. According to a news segment by Eric Whitney on NPR’s Morning Edition, “About 1 in 5 Medicare patients who leave the hospital come back within 30 days. Those […]

VN:F [1.9.7_1111]
Rating: +1 (from 1 vote)
0 comments Read the full article →

Advocates say FDA guidelines far too lax

For those who don’t know how the agency works, the following may come as a surprise, but it’s indeed the way the FDA does business.  While most state and federal agencies rely on regulations, and in most cases get really nasty when those regs aren’t followed, the FDA issues “guidance.” We’re talking voluntary guidance, not […]

VN:R_U [1.9.7_1111]
Rating: +4 (from 4 votes)
0 comments Read the full article →

FDA rejects another obesity drug, raising questions about market niche

In theory, pharmaceutical companies have billions of reasons to develop and market an obesity drug, given the epidemic weight problem in the U.S. The reality, however, is that sales of existing drugs have been modest, in part because the drugs don’t produce dramatic results on their own.  Weight losses of 1 percent to 3 percent of body weight over […]

VN:F [1.9.7_1111]
Rating: +5 (from 5 votes)
2 comments Read the full article →

← Previous Entries

  • 1
  • 2